$0.0 (5.63%)
Industry, Sector & symbol
Stock Exchange | Stockholm Stock Exchange |
CEO | Dr. Francois Regis Martelet M.D. |
Industry | Biotechnology |
Sector | Healthcare |
Current Symbol | SCOL.ST |
CUSIP | None |
CIK | None |
Web | https://www.scandiononcology.com |
Phone | 45 38 10 20 17 |
Currency | SEK |
Employees | 4 |
Country | DK |
Liquidity
Debt-to-Equity Ratio | 0.00 |
Payout Ratio | 0.00 |
Current Ratio | 4.82 |
Quick Ratio | 4.82 |
Cash Ratio | 3.16 |
Sales & Book Value
Annual Sales | $- |
Price / Sales | 0.00 |
Cash Flow | -0.34 |
Price / Cash Flow | -0.30 |
Price / Book | 0.21 |
Price Target and Rating
Average Stock Price Forecast | $ |
High Stock Price Forecast | $ |
Low Stock Price Forecast | $ |
Forecast Upside/Downside | % |
Consensus Rating | Sell |
Rating Score(0-5) | 2 |
Research Coverage | 0 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $-0.96 |
Trailing P/E Ratio | -0.16 |
PEG Ratio | 0.00 |
P/E Growth | 0.00 |
Net Income | $-39.2M |
Net Margin | 0.00% |
Pretax Margin | 0.00% |
Return on Equity | -119.05% |
Return on Assets | -114.39% |
Financials Score
AltmanZ Score | -12.73 |
Piotroski Score | 1.00 |
Working Capital | 17.9M |
Total Assets | 28.39M |
Ebit | -38.14M |
Market Cap | 16.47M |
Total Liabilities | 4.69M |
About Scandion Oncology A/S (STO:SCOL.ST) Stock
Scandion Oncology A/S, a clinical-stage biotechnology company, develops medicines for the treatment of chemotherapy resistance. Its lead product candidate includes the SCO-101, an oral compound that is in clinical Phase Ib and Phase II studies in cancer patients. The company's other product candidate is SCO-201, which is in preclinical trial for the treatment of solid tumors. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark. ...
Frequently Asked Questions
What is the current Scandion Oncology A/S (SCOL.ST) stock price?
Scandion Oncology A/S(STO:SCOL.ST) stock price is $0.075 in the last trading session. During the trading session, SCOL.ST stock reached the peak price of $5.64 while $0.065 was the lowest point it dropped to. The percentage change in SCOL.ST stock occurred in the recent session was 5.63% while the dollar amount for the price change in SCOL.ST stock was $0.0.
SCOL.ST's industry and sector of operation?
The STO listed SCOL.ST is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of SCOL.ST?
Mr. Morten Nissen
| General Counsel
Dr. Lars Damstrup
| Chief Medical Officer
Mr. Johnny Stilou M.S.
| Chief Financial Officer
Mr. Mads Kronborg
| Head of External Communication
Mr. Jan Stenvang M.S., Ph.D.
| Chief Scientific Officer
How many employees does SCOL.ST have?
Number of SCOL.ST employees currently stands at 4. SCOL.ST operates from Symbion, Copenhagen, None 2100, DK.
Link for SCOL.ST official website?
Official Website of SCOL.ST is: https://www.scandiononcology.com
How do I contact SCOL.ST?
SCOL.ST could be contacted at phone #45 38 10 20 17 and can also be accessed through its website. SCOL.ST operates from Symbion, Copenhagen, None 2100, DK.
How many shares of SCOL.ST are traded daily?
The average number of SCOL.ST shares traded daily for last 3 months was 617.91K.
What is the market cap of SCOL.ST currently?
The market value of SCOL.ST currently stands at $16.47M with its latest stock price at $0.075